上海金畔生物提供药物代谢物、杂质和中间体标准品
上海金畔生物科技有限公司是一家专业经营标准物质、标准品、化学试剂及相关技术服务创新型高科技企业。
自公司成立以来，一直以”客户满意”为公司核心价值观，产品主要应用于制药、生物、食品、环境、材料和农业等领域。凭借世界一流的产品和服务，金畔生物与广大客户建立了长期稳定的战略合作关系，被众多企业和科研机构认定为“指定供应商”，得到了政府部门的关怀和有力支持。本着始终拥有的创业激情和服务热忱，金畔生物已成长为我国重要的标准物质和标准品领域集成服务的领导者、中国最大的标准物质/标准品供应商之一。
金畔生物集后发优势与众多国际一流品牌合作，并陆续成为他们在中国区的总代理或者一级代理，现合作的优质供应商有：美国AccuStandard、APSC、MPBio、Sigma-Aldrich、NIST，爱尔兰Reagecon、Megazyme，英国LGC、Ultra，Iduron、日本和光（WAKO）、Shodex，德国Dr.E、PSS 等。同时，还提供美国USP标准物质、欧洲药典标准物质EDQM、加拿大TRC标准物质等。
上海金畔生物提供药物代谢物、杂质和中间体标准品，为您的检测分析提供强有力保障！
产品信息：
|
货号 |
品名 |
CAS No. |
分子式 |
包装规格 |
应用 |
|
H995870 |
25-Hydroxy Vitamin D3 3-Sulfate Sodium Salt (90%) |
|
C27H43NaO5S |
2.5mg/25mg |
24,25-二羟维生素 D3和25-羟维生素D3代谢物 |
|
M294540 |
3-Methylcrotonyl Glycine |
33008-07-0 |
C7H11NO3 |
100mg/1g |
3-methylcrotonylglycinuria代谢物 |
|
D441570 |
D,L-N,N-Didesmethyl Venlafaxine |
93413-77-5 |
C15H23NO2 |
25mg/250mg |
N,O-Didesmethylvenlafaxine合成中间体 |
|
H952550 |
rac 4’-Hydroxy Propranolol Sulfate |
87075-33-0 |
C16H21NO6S |
1mg/10mg |
non-β-blocking propranolol主要代谢物 |
|
B184980 |
2-Benzamido-2-methyl-4-(2-nitrophenyl)-4-oxobutanoic Acid Methyl Ester |
|
C19H18N2O6 |
50mg/500mg |
rac Kyurenine合成中间体 |
|
B208255 |
3-Benzoyl-4-(2-(2-nitrophenyl)-2-oxoethyl)-2-phenyloxazolidin-5-one |
|
C24H18N2O6 |
250mg/2.5g |
rac Kyurenine合成中间体 |
|
D459850 |
1,3-Diisopropylurea |
4128-37-4 |
C7H16N2O |
100mg/1g |
除草定降解物 |
|
H934500 |
Hydroxydehydro Nifedipine Carboxylate |
34783-31-8 |
C16H14N2O7 |
1mg/10mg |
硝苯地平主要代谢物 |
|
E589400 |
trans-trans-10,11-Epoxy Farnesenic Acid Methyl Ester |
24198-95-6 |
C16H26O3 |
25mg/250mg |
(2E,6E)-Farnesenic Acid代谢物 |
|
P481490 |
(E,E)-Piperic Acid S-[2-(Acetylamino)ethyl] Ester |
|
C16H17NO4S |
10mg/100mg |
(E,E)-胡椒酸类似物 |
|
A179500 |
5’-O-Acetyl (R)-Lisofylline |
174455-55-1 |
C15H22N4O4 |
10mg/100mg |
(R)-利索茶碱中间体 |
|
N877491 |
(S)-(-)-Nor Verapamil Hydrochloride |
123931-31-7 |
C26H37ClN2O4 |
1mg/10mg |
（S）异搏定代谢物 |
|
N368000 |
1-Naphthol β-D-Glucuronide |
17238-47-0 |
C16H16O7 |
1mg/10mg |
1-萘酚代谢物 |
|
E599175 |
(3β,22E,24ξ)-Ergosta-5,22-diene-3,24,25-triol 3-Acetate |
69425-75-8 |
C30H48O4 |
2.5mg/25mg |
24,25-二羟维生素 D2制备反应物 |
|
E599195 |
(3β,22E)-Ergosta-5,7,22-triene-3,24,25-triol 3-Acetate |
69425-77-0 |
C30H46O4 |
1mg/10mg |
24,25-二羟维生素 D2制备中间体 |
|
E599190 |
(3β,22E)-Ergosta-5,7,22-triene-3,24,25-triol |
|
C28H44O3 |
1mg/10mg |
24,25-二羟维生素 D2制备中间体 |
|
P338240 |
(3β,5α,8α,22E)-5,8-[N,N-(4-Phenylurazole)]-ergosta-6,22-diene-3,24,25-triol 3-Acetate |
|
C38H51N3O6 |
1mg/10mg |
24,25-二羟维生素 D2制备中间体 |
|
H947945 |
6-Hydroxy-2-methyl Isoborneol |
1138454-84-8 |
C11H20O2 |
2.5mg/25mg |
2-甲基异冰片代谢物 |
|
H947935 |
3-Hydroxy-2-methyl Isoborneol |
214074-24-5 |
C11H20O2 |
10mg/100mg |
2-甲基异冰片代谢物 |
|
B286440 |
1-[4-Benzyloxy-3-methoxyphenyl]-2-[methyl(phenylmethyl)amino]ethanone |
|
C24H25NO3 |
100mg/1g |
3-甲氧基肾上腺素中间体 |
|
H943555 |
rac 3-Hydroxyisobutyric Acid |
2068-83-9 |
C4H8O3 |
1mg/10mg |
3-羟基异丁酸脱氢酶代谢物 |
|
H952535 |
4-Hydroxy Propranolol β-D-Glucuronide (Mixture of Diastereomers) |
94731-13-2 |
C22H29NO9 |
1mg/10mg |
4-羟基普萘洛尔代谢物 |
|
P141000 |
Paliperidone |
144598-75-4 |
C23H27FN4O3 |
25mg/250mg |
5 -羟色胺(5-HT2)联合剂和多巴胺(D2)受体拮抗剂 |
|
B691910 |
(3S)-1,3-Bis-O-(tert-Butyldimethylsilyl)-3-hydroxy-5,6-trans-vitamin D2 |
111594-58-2 |
C40H72O2Si2 |
5mg/50mg |
5,6-反式-维生素D2衍生物 |
|
A763800 |
9-β-D-Arabinofuranosyl-2-fluorohypoxanthine |
83480-48-2 |
C10H11FN4O5 |
5mg/50mg |
9-β-D-arabinofuranosyl-2-氟腺嘌呤主要代谢物 |
|
A168050 |
N-Acetyl Adamantamine |
880-52-4 |
C12H19NO |
1g/10g |
Adamantamine代谢物 |
|
C963000 |
7-Cyano DAMPA Ethyl Ester |
|
C18H18N8O2 |
1mg/10mg |
DAMPA代谢物制备中间体 |
|
D314000 |
N,N’-Diacetyl DAMPA Ethyl Ester |
|
C21H23N7O4 |
1mg/10mg |
DAMPA代谢物制备中间体 |
|
H931515 |
7-Hydroxy DAMPA Methyl Ester |
|
C16H17N7O3 |
1mg/10mg |
DAMPA代谢物制备中间体 |
|
E558530 |
Entacapone-3’-sulfate Sodium Salt |
158069-72-8 |
C14H14N3NaO8S |
5mg/50mg |
Entacaponec代谢物 |
|
E558535 |
cis-Entacapone-3’-sulfate Sodium Salt |
158069-74-0 |
C14H14N3NaO8S |
1mg/10mg |
Entacaponec代谢物 |
|
L397740 |
Licofelone Acyl-β-D-glucuronide |
1033702-58-7 |
C29H30ClNO8 |
5mg |
Licofeline M1代谢物 |
|
H949225 |
(R)-5-(4-Hydroxyphenyl)-5-ethylhydantoin |
65567-33-1 |
C11H12N2O3 |
10mg/100mg |
Nirvanol代谢物 |
|
H949226 |
(S)-5-(4-Hydroxyphenyl)-5-ethylhydantoin |
65567-35-3 |
C11H12N2O3 |
25mg/250mg |
Nirvanol代谢物 |
|
N535010 |
N’-Nitrosonornicotine N-β-D-Glucuronide (Mixture Of Diastereomers) X Hydrate |
350508-25-7 |
C15H19N3O7 |
1mg/10mg |
N’-亚硝基去甲基尼古丁代谢物 |
|
N535015 |
rac-N’-Nitrosonornicotine 1-N-Oxide |
1314916-69-2 |
C9H11N3O2 |
5mg/50mg |
N’-亚硝基去甲基尼古丁代谢物 |
|
A622535 |
4-(2-Aminophenyl)-2-benzamido-2-methyl-4-oxobutanoic Acid |
|
C18H18N2O4 |
10mg/100mg |
rac Kyurenine 杂质 |
|
M315100 |
rac α-Methyl Kynurenine |
|
C11H14N2O3 |
1mg/10mg |
rac Kyurenine 杂质 |
|
M303070 |
2-[(3S,4S,5S,6R)-7-Hydroxy-4,6-dimethoxy-3,5-dimethylheptyl]-5,7-dimethoxy-8-(methoxymethoxy)-3-methyl-2,3-dihydro-4H-1-benzopyran-4-one |
276690-22-3 |
C25H40O9 |
0.5mg/5mg |
Stigmatellin A制备中间体 |
|
S688015 |
SU-5402 Ethyl Ester |
|
C19H20N2O3 |
5mg/50mg |
SU 5402合成副产物 |
|
D455105 |
1α,24-Dihydroxy Vitamin D2 |
124043-51-2 |
C28H44O3 |
10mg/25mg |
vitamin D2天然代谢物 |
|
A511615 |
Albendazole Sulfone |
75184-71-3 |
C12H15N3O4S |
10mg/100mg |
阿苯达唑代谢物 |
|
D559070 |
Doxorubicinone |
24385-10-2 |
C21H18O9 |
2mg/20mg |
阿霉素代谢物 |
|
D292570 |
4-O-Desmethyldoxorubicinone |
65446-19-7 |
C20H16O9 |
1mg/10mg |
阿霉素酮类似物 |
|
A575205 |
Almotriptan Metabolite M2 |
603137-41-3 |
C17H25N3O4S |
1mg/10mg |
阿莫曲坦代谢物 |
|
H797800 |
7-Hydroxy Amoxapine |
37081-76-8 |
C17H16ClN3O2 |
1mg/10mg |
阿莫沙平代谢物 |
|
H797805 |
8-Hydroxy Amoxapine |
61443-78-5 |
C17H16ClN3O |
1mg/10mg |
阿莫沙平代谢物 |
|
B208135 |
4-(2-Benzoyl-4-chlorophenyl)-5-methyl-4H-1,2,4-triazole-3-carboxaldehyde |
36916-20-8 |
C17H12ClN3O2 |
10mg/100mg |
阿普唑仑杂质中检体 |
|
B657150 |
2-(R)-[1-(R)-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(S)-fluorophenylmorpholine |
171338-27-5 |
C20H18F7NO2 |
10mg/100mg |
阿瑞匹坦代谢物 |
|
B657155 |
2-(R)-[1-(S)-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(S)-fluorophenylmorpholine |
170729-79-0 |
C20H18F7NO2 |
10mg/100mg |
阿瑞匹坦代谢物 |
|
A729810 |
Aprepitant β-Glucuronide Sodium Salt |
|
C29H28F7N4NaO9 |
1mg/10mg/25mg |
阿瑞匹坦代谢物 |
|
A729815 |
Aprepitant 2,3,4-Tri-O-acetyl-β-Glucuronide Methyl Ester |
|
C37H41F7N4O12 |
1mg/10mg |
阿瑞匹坦衍生物 |
|
A729820 |
Aprepitant Di-(2,3,4-tri-O-acetyl-β-Glucuronide Methyl Ester) |
|
C50H57F7N4O21 |
1mg/10mg |
阿瑞匹坦衍生物 |
|
B657165 |
(5S,6R)-6-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-5-(4-fluorophenyl)-3-morpholinone |
419574-04-2 |
C20H16F7NO3 |
1mg/10mg |
阿瑞匹坦有效代谢物 |
|
D290750 |
O-Desmethyl Astemizole |
73736-50-2 |
C27H29FN4O |
1mg/10mg |
阿司咪唑代谢物 |
|
S088130 |
Salicylic Acid β-D-O-Glucuronide |
7695-70-7 |
C13H14O9 |
5mg/50mg |
阿司匹林代谢物 |
|
M326590 |
Methyl Salicylate β-D-O-Glucuronide Triacetate Methyl Ester |
101231-54-3 |
C21H24O12 |
25mg/250mg |
阿司匹林代谢物合成中间体 |
|
M326585 |
Methyl Salicylate β-D-O-Glucuronide Methyl Ester |
226932-59-8 |
C15H18O9 |
10mg/100mg |
阿司匹林代谢物合成中间体 |
|
D193260 |
Dapsone Hydroxylamine |
32695-27-5 |
C12H12N2O3S |
10mg/100mg |
氨苯砜代谢物 |
|
D425970 |
4-(6,8-Dibromo-3(4H)-quinazolinyl)-cyclohexanol |
|
C14H16Br2N2O |
10mg/100mg |
氨溴索杂质 |
|
A601985 |
trans-4-[[(2-Amino-5-bromophenyl)methyl]amino]-cyclohexanol |
101900-43-0 |
C13H19BrN2O |
100mg/1g |
氨溴索杂质 |
|
D288731 |
Desethyl Amiodarone Hydrochloride |
96027-74-6 |
C23H26ClI2NO3 |
10mg/100mg |
胺碘酮代谢物 |
|
D449135 |
10,11-Dihydro-10-hydroxy Carbamazepine |
29331-92-8 |
C15H14N2O2 |
5mg/50mg |
奥卡西平代谢物 |
|
D292190 |
N-Desmethyl Olopatadine |
113835-92-0 |
C20H21NO3 |
2.5mg/25mg |
奥洛他定代谢物 |
|
D293060 |
N-Desmethyl Olopatadine Methyl Ester Trifluoroacetic Acid Salt |
|
C23H24F3NO5 |
2.5mg/25mg |
奥洛他定代谢物 |
|
H948865 |
5-O-Desmethyl Omeprazole |
151602-49-2 |
C16H17N3O3S |
5mg/50mg |
奥美拉唑代谢物 |
|
D292120 |
5-O-Desmethyl Omeprazole |
151602-49-2 |
C16H17N3O3S |
2.5mg/25mg |
奥美拉唑代谢物 |
|
H948860 |
4-Hydroxy Omeprazole, Preparation Kit |
301669-82-9 |
C16H17N3O3S |
5mg/50mg |
奥美拉唑代谢物 |
|
O635030 |
Omeprazole Sulfone N-Oxide |
158812-85-2 |
C17H19N3O5S |
2.5mg/25mg |
奥美拉唑代谢物 |
|
A187355 |
4-Acetyloxy Omeprazole |
1246814-65-2 |
C18H19N3O4S |
10mg/100mg |
奥美拉唑代谢物制备中间体 |
|
H948845 |
4-Hydroxy Omeprazole Sulfide |
103876-98-8 |
C16H17N3O2S |
10mg/100mg |
奥美拉唑代谢物制备中间体 |
|
M262560 |
8(9)-Methoxy-1,3-dimethyl-12-thioxopyrido[1’,2’:3,4]imidazo[1,2-a]benzimidazol-2-(12H)-one (Mixture of Regioisomers) |
125656-82-8+125656-83-9 |
C16H13N3O2S |
2.5mg/25mg |
奥美拉唑杂质 |
|
D290515 |
4-Desmethoxy-4-nitro Omeprazole Sulfone |
1076199-93-3 |
C16H16N4O5S |
1mg/10mg |
奥美拉唑杂质 B |
|
D290500 |
4-Desmethoxy-4-nitro Omeprazole |
317807-10-6 |
C16H16N4O4S |
1mg/10mg |
奥美拉唑杂质 C |
|
C441660 |
Cimetidine Amide Dihydrochloride |
52568-80-6 |
C10H20Cl2N6OS |
5mg/50mg |
奥美拉唑杂质 C |
|
D296760 |
N-Desmethyl Vinblastine |
18172-50-4 |
C45H56N4O9 |
1mg/10mg |
奥美拉唑杂质 C. |
|
E649970 |
Erythromycin A Enol Ether |
33396-29-1 |
C37H65NO12 |
10mg/100mg |
奥美拉唑杂质 E. |
|
D290400 |
4-Desmethoxy-4-chloro Omeprazole Sulfide |
220757-74-4 |
C16H16ClN3OS |
1mg/10mg |
奥美拉唑杂质 G |
|
D290390 |
4-Desmethoxy-4-chloro Omeprazole |
863029-89-4 |
C16H16ClN3O2S |
1mg/10mg |
奥美拉唑杂质D |
|
D290510 |
4-Desmethoxy-4-nitro Omeprazole Sulfide |
142885-91-4 |
C16H16N4O3S |
1mg/10mg |
奥美拉唑杂质F |
|
O550015 |
Olmesartan Medoxomil Methyl Ether |
896419-17-3 |
C30H32N6O6 |
1mg/10mg |
奥美沙坦酯杂质 |
|
C379530 |
3-(4-Chlorophenyl)-4-hydroxybutyric Acid Sodium Salt |
|
C10H10ClNaO3 |
2.5mg/25mg |
巴氯芬代谢物 |
|
C379532 |
3-(4-Chlorophenyl-d4)-4-hydroxybutyric Acid Sodium Salt |
|
C10H6D4ClNaO3 |
1mg/10mg |
巴氯芬氘代代谢物 |
|
H952520 |
4-Hydroxy Propranolol β-D-Glucuronide Methyl Ester (Mixture of Diastereomers) |
|
C23H31NO9 |
1mg/10mg |
保护的4羟基心得安代谢物 |
|
H948965 |
4’-Hydroxyphenprocoumon |
55789-09-8 |
C18H16O4 |
100mg/1g |
苯丙香豆素代谢物 |
|
D281945 |
Desacetyl Bisacodyl |
72901-16-7 |
C20H17NO3 |
5mg/50mg |
比沙可啶制备杂质 |
|
H952080 |
Hydroxy Pioglitazone (M-II) |
101931-00-4 |
C19H20N2O4S |
1mg/10mg |
吡格列酮代谢物 |
|
K200600 |
Keto Pioglitazone (M-III) |
146062-45-5 |
C19H18N2O4S |
1mg/10mg |
吡格列酮代谢物 |
|
M262412 |
3-Methoxy Dopamine-d4 Hydrochloride (Major) |
1216788-76-9 |
C9H10D4ClNO2 |
10mg/50mg |
标记的多巴胺代谢物 |
|
F102272 |
Famotidine-13C,d4 Amide Impurity |
|
C713CH9D4N5S2 |
1mg/10mg |
标记的法莫替丁杂质 |
|
M323075 |
6-O-Methyl Mycophenolic Acid Methyl Ester |
60435-90-7 |
C19H24O6 |
2.5mg/25mg |
标记的霉酚酸杂质 |
|
D436452 |
Diclofenac-d4 |
153466-65-0 |
C14H7D4Cl2NO2 |
1mg/10mg |
标记的双氯芬酸 |
|
H918292 |
4’’-Hydroxy-cilostazol-d5 |
|
C20H22D5N5O3 |
10mg/25mg/50mg |
标记的西洛他唑代谢物 |
|
B285610 |
7-Benzyloxy-2-(2,2-diphenyl-1,3-benzodioxol-5-yl)-5-hydroxy-H-1-benzopyran-4-one |
|
C35H24O6 |
10mg/100mg |
标记的香叶木素合成中间体 |
|
H950770 |
4-Hydroxy Propofol |
1988-10-9 |
C12H18O2 |
1mg/10mg |
丙泊酚代谢物 |
|
P838315 |
Propylthiouracil N-β-D-Glucuronide [DISCONTINUED] |
33987-24-5 |
C13H18N2O7S |
1mg/10mg |
丙基硫氧嘧啶代谢物 |
|
P838345 |
Propylthiouracil N-β-D-Glucuronide Sodium Salt |
|
C13H17N2NaO7S |
1mg/10mg |
丙基硫氧嘧啶代谢物 |
|
H943400 |
2-Hydroxy Imipramine |
303-70-8 |
C19H24N2O |
5mg/50mg |
丙咪嗪代谢物 |
|
I466000 |
Imipramine N-Oxide Monohydrate |
6829-98-7 |
C19H26N2O2 |
10mg/100mg |
丙咪嗪代谢物 |
|
H993000 |
3-Hydroxy Valproic Acid |
58888-84-9 |
C8H16O3 |
5mg/50mg |
丙戊酸代谢物 |
|
H993005 |
4-Hydroxy Valproic Acid Sodium Salt |
1216888-06-0 |
C8H15NaO3 |
100mg/1g |
丙戊酸代谢物 |
|
K315500 |
3-Keto Valproic Acid Sodium Salt |
1184991-15-8 |
C8H13NaO3 |
100mg/1g |
丙戊酸代谢物 |
|
P835300 |
2-Propylglutaric Acid |
32806-62-5 |
C8H14O4 |
2.5mg/25mg |
丙戊酸代谢物 |
|
P838290 |
(E,Z)-2-Propyl-2,4-pentadienoic Acid |
72010-18-5 |
C8H12O2 |
1mg/10mg |
丙戊酸代谢物 |
|
P838300 |
(E,Z) 2-Propyl-2-pentenoic Acid |
60218-41-9 |
C8H14O2 |
1mg/10mg |
丙戊酸代谢物 |
|
P838305 |
(+/-)-2-Propyl-4-pentenoic Acid |